toxic medicine

  • Deadly Cough Syrup Scandal: Pharmaceutical Owner Arrested in Madhya Pradesh Child Deaths Case

    Deadly Cough Syrup Scandal: Pharmaceutical Owner Arrested in Madhya Pradesh Child Deaths Case

    Oct 09, 2025 04:24 pm CST

    The owner of Sresan Pharma, Ranganathan Govindan, has been arrested in Chennai following the deaths of 20 children in Chhindwara, Madhya Pradesh, who consumed toxic Coldrif cough syrup. Police conducted a meticulously planned operation to apprehend the suspect, who had been evading authorities since the tragedy came to light. Investigations reveal the company was operating despite being struck off official registers, raising serious questions about regulatory oversight in India's pharmaceutical industry.

  • Deadly Contamination: How Substandard Manufacturing Led to Fatal Cough Syrup Poisoning of 16 Children

    Deadly Contamination: How Substandard Manufacturing Led to Fatal Cough Syrup Poisoning of 16 Children

    Oct 06, 2025 10:50 pm CST

    An investigation into the fatal Coldrif cough syrup reveals shocking manufacturing conditions at Sresan Pharmaceuticals, where industrial chemicals replaced pharmaceutical-grade ingredients, leading to 16 children's deaths in Madhya Pradesh. Inspectors found 39 critical and 325 major violations, including untested raw materials, untrained staff, and toxic levels of diethylene glycol—nearly 500 times above permissible limits.

  • Contaminated Cough Syrup Crisis: Tamil Nadu

    Contaminated Cough Syrup Crisis: Tamil Nadu's Swift Action Contrasts Madhya Pradesh's Delayed Response in Child Deaths Investigation

    Oct 04, 2025 02:47 pm CST

    A comparative analysis of two Indian states' responses to potentially lethal contaminated cough syrup: While Tamil Nadu identified and banned Coldrif Syrup containing 48.6% Diethylene Glycol within 24 hours, Madhya Pradesh continues to delay action despite nine child fatalities showing classic signs of industrial solvent poisoning, raising serious questions about public health priorities and accountability in pharmaceutical regulation.